Literature DB >> 9191742

Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism.

K M Shakir1, J P Chute, B S Aprill, A A Lazarus.   

Abstract

Recent studies have shown that under experimental conditions ferrous sulfate may reduce the gastrointestinal absorption of orally administered levothyroxine sodium in patients with primary hypothyroidism. We describe a patient who became hypothyroid while taking ferrous sulfate. The hypothyroid status was corrected by increasing the dose of levothyroxine. Subsequently, when ferrous sulfate was discontinued, the patient became hyperthyroid while taking the higher dose of thyroid hormone preparation. Since both hypothyroidism and iron deficiency anemia may coexist, additional thyroid function testing is recommended in patients treated concurrently with ferrous sulfate and L-thyroxine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191742     DOI: 10.1097/00007611-199706000-00011

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  9 in total

1.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

2.  Identifying Predictors of Prolonged Levothyroxine Dose Adjustment After Thyroidectomy.

Authors:  Tenzin S Atruktsang; Nick A Zaborek; Joseph R Imbus; Kristin Long; Susan C Pitt; Rebecca S Sippel; David F Schneider
Journal:  J Surg Res       Date:  2019-05-09       Impact factor: 2.192

3.  Concurrent Milk Ingestion Decreases Absorption of Levothyroxine.

Authors:  Deborah A Chon; Tamar Reisman; Jane E Weinreb; Jerome M Hershman; Angela M Leung
Journal:  Thyroid       Date:  2018-03-28       Impact factor: 6.568

Review 4.  A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism.

Authors:  Philippe Colucci; Corinne Seng Yue; Murray Ducharme; Salvatore Benvenga
Journal:  Eur Endocrinol       Date:  2013-03-15

Review 5.  Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature.

Authors:  Mark Messina
Journal:  Nutrients       Date:  2016-11-24       Impact factor: 5.717

Review 6.  Review of Heterotopic Thyroid Autotransplantation.

Authors:  Mahmoud Sakr; Ahmed Mahmoud
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-05-24       Impact factor: 3.372

Review 7.  Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient's Lifetime.

Authors:  Leonidas H Duntas; Jacqueline Jonklaas
Journal:  Adv Ther       Date:  2019-09-04       Impact factor: 3.845

Review 8.  An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

Authors:  Stefano Stagi; Giovanna Municchi; Marta Ferrari; Malgorzata Gabriela Wasniewska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 9.  Levothyroxine Interactions with Food and Dietary Supplements-A Systematic Review.

Authors:  Agnieszka Wiesner; Danuta Gajewska; Paweł Paśko
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.